BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 32389340)

  • 1. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.
    da Silva AA; do Carmo JM; Li X; Wang Z; Mouton AJ; Hall JE
    Can J Cardiol; 2020 May; 36(5):671-682. PubMed ID: 32389340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations?
    Hall JE; Brands MW; Zappe DH; Alonso Galicia M
    Proc Soc Exp Biol Med; 1995 Apr; 208(4):317-29. PubMed ID: 7700881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-associated hypertension. Hyperinsulinemia and renal mechanisms.
    Hall JE; Brands MW; Hildebrandt DA; Mizelle HL
    Hypertension; 1992 Jan; 19(1 Suppl):I45-55. PubMed ID: 1730454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome: insulin resistance.
    Mikhail N
    Curr Hypertens Rep; 2009 Apr; 11(2):156-8. PubMed ID: 19278606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, energy balance and sympathetic nervous system activity.
    Landsberg L
    Clin Exp Hypertens A; 1990; 12(5):817-30. PubMed ID: 2208753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and hyperinsulinemia in hypertension.
    Weidmann P; Böhlen L; de Courten M
    J Hypertens Suppl; 1995 Aug; 13(2):S65-72. PubMed ID: 8576790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that influence the risk of hypertension in obese individuals.
    Coatmellec-Taglioni G; Ribière C
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sympathetic nervous system and neuropeptides in obesity hypertension.
    Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S
    Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.
    Kalil GZ; Haynes WG
    Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and hypertension: roles of hyperinsulinemia, sympathetic nervous system and intrarenal mechanisms.
    Brands MW; Hall JE; Van Vliet BN; Alonso-Galicia M; Herrera GA; Zappe D
    J Nutr; 1995 Jun; 125(6 Suppl):1725S-1731S. PubMed ID: 7782935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of abnormal renal sodium handling in obesity hypertension.
    Hall JE
    Am J Hypertens; 1997 May; 10(5 Pt 2):49S-55S. PubMed ID: 9160781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperinsulinism/insulin resistance: cause, effect or marker of essential arterial hypertension?].
    Greco D; Sinagra D
    G Ital Cardiol; 1995 Feb; 25(2):207-16. PubMed ID: 7642026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and insulin disorders.
    Imazu M
    Curr Hypertens Rep; 2002 Dec; 4(6):477-82. PubMed ID: 12419178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia.
    Flack JM; Sowers JR
    Am J Med; 1991 Jul; 91(1A):11S-21S. PubMed ID: 1867224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving obesity and blood pressure.
    Tanaka M
    Hypertens Res; 2020 Feb; 43(2):79-89. PubMed ID: 31649313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators of sympathetic activation in metabolic syndrome obesity.
    Straznicky NE; Eikelis N; Lambert EA; Esler MD
    Curr Hypertens Rep; 2008 Dec; 10(6):440-7. PubMed ID: 18959829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance, hyperinsulinemia, and obesity-associated hypertension.
    Brands MW; Hall JE
    J Am Soc Nephrol; 1992 Nov; 3(5):1064-77. PubMed ID: 1482747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, hypertension, and sympathetic nervous system activity.
    Corry DB; Tuck ML
    Curr Hypertens Rep; 1999; 1(2):119-26. PubMed ID: 10981052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.